STING1 and head and neck squamous cell carcinoma: This immunosuppression state could be mitigated with a STING-inducing nanosatellite vaccine (containing a cGAMP and HPV16 E6/E7 peptide), which promotes APC maturation and enlarges tumor-specific CTLs to inhibit the immune escape of HNSCC.